374 related articles for article (PubMed ID: 30833131)
1. A systematic review of outcome in intramedullary ependymoma and astrocytoma.
Hamilton KR; Lee SS; Urquhart JC; Jonker BP
J Clin Neurosci; 2019 May; 63():168-175. PubMed ID: 30833131
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with progression-free survival and long-term neurological outcome after resection of intramedullary spinal cord tumors: analysis of 101 consecutive cases.
Garcés-Ambrossi GL; McGirt MJ; Mehta VA; Sciubba DM; Witham TF; Bydon A; Wolinksy JP; Jallo GI; Gokaslan ZL
J Neurosurg Spine; 2009 Nov; 11(5):591-9. PubMed ID: 19929363
[TBL] [Abstract][Full Text] [Related]
3. Intramedullary spinal cord ependymoma and astrocytoma: intraoperative frozen-section diagnosis, extent of resection, and outcomes.
Hongo H; Takai K; Komori T; Taniguchi M
J Neurosurg Spine; 2018 Oct; 30(1):133-139. PubMed ID: 30485241
[TBL] [Abstract][Full Text] [Related]
4. Predictors of survival in patients with spinal ependymoma.
Lin Y; Smith ZA; Wong AP; Melkonian S; Harris DA; Lam S
Neurol Res; 2015 Jul; 37(7):650-5. PubMed ID: 25917046
[TBL] [Abstract][Full Text] [Related]
5. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
Lin Y; Jea A; Melkonian SC; Lam S
J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
[TBL] [Abstract][Full Text] [Related]
6. Management and outcome in adult intramedullary spinal cord tumours: a 20-year single institution experience.
Boström A; Kanther NC; Grote A; Boström J
BMC Res Notes; 2014 Dec; 7():908. PubMed ID: 25495874
[TBL] [Abstract][Full Text] [Related]
7. An integrative analysis of treatment, outcomes and prognostic factors for primary spinal anaplastic ependymomas.
Chen P; Sui M; Ye J; Wan Z; Chen F; Luo C
J Clin Neurosci; 2015 Jun; 22(6):976-80. PubMed ID: 25769252
[TBL] [Abstract][Full Text] [Related]
8. Pathology of spinal ependymomas: an institutional experience over 25 years in 134 patients.
Tarapore PE; Modera P; Naujokas A; Oh MC; Amin B; Tihan T; Parsa AT; Ames CP; Chou D; Mummaneni PV; Weinstein PR
Neurosurgery; 2013 Aug; 73(2):247-55; discussion 255. PubMed ID: 23670032
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
[TBL] [Abstract][Full Text] [Related]
10. Impact of tumor histology on resectability and neurological outcome in primary intramedullary spinal cord tumors: a single-center experience with 102 patients.
Karikari IO; Nimjee SM; Hodges TR; Cutrell E; Hughes BD; Powers CJ; Mehta AI; Hardin C; Bagley CA; Isaacs RE; Haglund MM; Friedman AH
Neurosurgery; 2015 Mar; 76 Suppl 1():S4-13; discussion S13. PubMed ID: 25692367
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rates and functional outcome after resection of intrinsic intramedullary tumors.
Schebesch KM; Mueller S; Wendl C; Brawanski A; Riemenschneider MJ; Proescholdt M
Clin Neurol Neurosurg; 2015 Jul; 134():60-6. PubMed ID: 25950925
[TBL] [Abstract][Full Text] [Related]
12. Pediatric low-grade and ependymal spinal cord tumors.
Merchant TE; Kiehna EN; Thompson SJ; Heideman R; Sanford RA; Kun LE
Pediatr Neurosurg; 2000 Jan; 32(1):30-6. PubMed ID: 10765136
[TBL] [Abstract][Full Text] [Related]
13. Long-term disease and neurological outcomes in patients with pediatric intramedullary spinal cord tumors.
Ahmed R; Menezes AH; Awe OO; Torner JC
J Neurosurg Pediatr; 2014 Jun; 13(6):600-12. PubMed ID: 24702616
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors and Treatment of Spinal Astrocytomas: A Multi-institutional Cohort Analysis.
Zou Y; Sun J; Zhou Y; Bai HX; Huang X; Babu R; Landi A; Foong KS; Zhang Z; Woo JH; Tao Y; Li X; Tang X; Xiao B; Zhang PJ; Yang L
Spine (Phila Pa 1976); 2018 May; 43(10):E565-E573. PubMed ID: 29135884
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases.
Savoor R; Sita TL; Dahdaleh NS; Helenowski I; Kalapurakal JA; Marymont MH; Lukas R; Kruser TJ; Smith ZA; Koski T; Ganju A; Sachdev S
J Neurooncol; 2021 Jan; 151(2):241-247. PubMed ID: 33179213
[TBL] [Abstract][Full Text] [Related]
16. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
Kukreja S; Ambekar S; Sin AH; Nanda A
J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
[TBL] [Abstract][Full Text] [Related]
17. Ependymoma of the Spinal Cord in Children: A Retrospective French Study.
Szathmari A; Zerah M; Vinchon M; Dufour C; Gimbert E; Di Rocco F; Chabaud S; Conter C; Mottolese C; Frappaz D
World Neurosurg; 2019 Jun; 126():e1035-e1041. PubMed ID: 30877001
[TBL] [Abstract][Full Text] [Related]
18. Treatment, prognostic factors, and outcomes in spinal cord astrocytomas.
Fakhreddine MH; Mahajan A; Penas-Prado M; Weinberg J; McCutcheon IE; Puduvalli V; Brown PD
Neuro Oncol; 2013 Apr; 15(4):406-12. PubMed ID: 23322747
[TBL] [Abstract][Full Text] [Related]
19. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
20. Pediatric intramedullary spinal cord tumors: a single center experience.
Kutluk T; Varan A; Kafalı C; Hayran M; Söylemezoğlu F; Zorlu F; Aydın B; Yalçın B; Akyüz C; Büyükpamukçu M
Eur J Paediatr Neurol; 2015 Jan; 19(1):41-7. PubMed ID: 25457509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
